ANL vs BIIB: Which Stock is Better?

Side-by-side comparison of Adlai Nortye Ltd and Biogen Inc in 2026

Comparison Updated:

ANL

Adlai Nortye Ltd

$8.38

BIIB

Biogen Inc

$184.87

Key Metrics Comparison

MetricANLBIIBWinner
Market Cap$295.57M$27.60BBIIB
P/E RatioN/A21.59BIIB
EPS (TTM)$N/A$8.71BIIB
Revenue Growth1.2%-0.1%ANL
Gross Margin100.0%78.9%ANL

Analyze ANL

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANL or BIIB a better investment?

Comparing ANL and BIIB: Adlai Nortye Ltd has a market cap of $295.57M while Biogen Inc has $27.60B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANL and BIIB?

ANL (Adlai Nortye Ltd) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANL or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANL or BIIB?

ANL has higher revenue growth at 1.2% vs -0.1% for BIIB.

Which company is more profitable: ANL or BIIB?

Adlai Nortye Ltd (ANL) has higher gross margins at 100.0% compared to 78.9% for BIIB.

Which is the larger company: ANL or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $27.60B compared to $295.57M for ANL.

Should I buy ANL or BIIB in 2026?

Both ANL and BIIB have investment merit. ANL trades at $8.38 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANL and BIIB stock?

Key differences: Market Cap ($295.57M vs $27.60B), P/E Ratio (N/A vs 21.6x), Revenue Growth (1.2% vs -0.1%), Gross Margin (100.0% vs 78.9%).

Popular Stock Comparisons